This article was originally published on TipRanks.com Synthetic biotechnology company Amyris, Inc.
This article was originally published on TipRanks.com Biotech firm Amyris, Inc.
This article was originally published on TipRanks.com Biotechnology and renewable chemical company Amyris, Inc.
Amyris, Inc. (AMRS), a leader in the development of sustainable ingredients through synthetic biotechnology, announced the acquisition of OLIKA Inc.
The dog days of summer have come to a close, and investors want to know what the fall has in store for the …
Amyris, Inc. (NASDAQ:AMRS) announced that it has entered into a product development and production agreement for a new class of human nutrition ingredients …
Amyris Inc (NASDAQ:AMRS) announced that it has entered into a product development and production agreement for Vitamin A with Koninklijke DSM N.V.
Amyris Inc (NASDAQ:AMRS) announced agreements for $50 million in equity financing as part of the second tranche of its previously announced financing. The …
Amyris Inc (NASDAQ:AMRS) and the Government of Queensland, Australia announced the next step their plans to develop a leading industrial biotechnology hub in …
Amyris, Inc. (NASDAQ:AMRS) announced that it expects revenue related to its Vitamin E partnership with Nenter to more than double based on the …
